Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.74
-1.66 (-4.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,613 | 1,446 | 649 | - | - |
| Market Cap Growth | 412.05% | 122.86% | - | - | - |
| Enterprise Value | 1,134 | 945 | 330 | - | - |
| Last Close Price | 33.74 | 30.34 | 17.74 | - | - |
| PB Ratio | 3.33 | 2.98 | 2.12 | - | - |
| P/TBV Ratio | 3.33 | 2.98 | 2.12 | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.05 | 0.54 |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.99 | -1.00 | -1.06 |
| Net Debt / EBITDA Ratio | 3.86 | 3.86 | 3.70 | 3.91 | 3.55 |
| Net Debt / FCF Ratio | 5.44 | 5.44 | 4.52 | 4.90 | 5.39 |
| Quick Ratio | 25.75 | 25.75 | 34.82 | 16.75 | 18.74 |
| Current Ratio | 26.17 | 26.17 | 35.34 | 17.14 | 18.80 |
| Return on Equity (ROE) | -28.22% | -28.22% | -35.09% | -43.36% | - |
| Return on Assets (ROA) | -18.90% | -18.90% | -22.07% | -24.18% | - |
| Return on Capital Employed (ROCE) | -25.40% | -25.40% | -27.10% | -24.70% | -19.60% |
| Earnings Yield | -6.91% | -7.71% | -12.07% | - | - |
| FCF Yield | -5.46% | -6.09% | -10.36% | - | - |
| Buyback Yield / Dilution | -87.74% | -87.74% | -1277.25% | -93.74% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.